Medical Specialty >> Pharmacy
Many Deaths Labeled ‘Cardiac Arrest’ Could Be Drug ODs: Study
5:00 PM CDT.
By E.J. MundellHealthDay Reporter Read article
- Baby’s Meningitis Case Highlights Growing Danger of Antibiotic Resistance
- Will a Cheap Pill Cure Gonorrhea? New Test Can Tell
- U.S. Women More Likely to Skip Meds Than Men, Study Finds
- New Drug May Beat Older One at Preventing MS Relapse
JOURNAL UPDATE
Prenatal Cannabis Exposure May Harm Child Neurodevelopment
12:00 PM CDT. Maternal cannabis use during pregnancy tied to higher risk for autism spectrum disorder in offspring- Persistent Opioid Use Seen in ~10 Percent of Patients After Cardiac Surgery
- Serine 91 Genotype of gyrA Gonorrhea Successfully Treated With Ciprofloxacin
- Physician’s Briefing Weekly Coronavirus Roundup
MONTHLY JOURNAL SUMMARY
July 2020 Briefing - Pharmacy
August 03, 2020. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
Bevacizumab for breast cancer: FDA grants a stay of execution
Dr. Alberto De la Guerra.
The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.
MEDICAL FOCUS
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By namabcAs I understand, this is a great step of development that we can use to save many people from horrible diseases. and i also hope Dr.Lain and your partners…
